Café

© 2026 Longbridge｜Terms of Service Privacy Policy

MBIO

MBIO

0.54293.05%( -0.0171 )

LongbridgeAI

Eli Lilly will acquire biotech company CrossBridge Bio for up to $300 million in cash

Wallstreetcn

Apr 14, 2026 at 12:07 PM

Eli Lilly will acquire biotech company CrossBridge Bio for up to $300 million in cash.

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Eli Lilly

USLLY

-0.88%

Mustang Bio

USMBIO

-3.05%

BridgeBio Oncology Therapeutics

USBBOT

+0.90%